Do analysts prefer QUCY or OPXS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25 Optex Systems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00

Which has better valuation & earnings, QUCY or OPXS?

Optex Systems has higher revenue and earnings than Mainz Biomed. Mainz Biomed is trading at a lower price-to-earnings ratio than Optex Systems, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mainz Biomed $540K 36.11 -$16.21M -$10.37 N/A Optex Systems $41.34M 1.76 $5.15M $0.55 19.00

Do analysts rate MOB or QUCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mobilicom 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25

Which has higher earnings & valuation, MOB or QUCY?

Mainz Biomed has lower revenue, but higher earnings than Mobilicom. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mobilicom $3.36M 18.10 -$23.73M N/A N/A Mainz Biomed $540K 36.11 -$16.21M -$10.37 N/A

Is MOB or QUCY more profitable?

Company Net Margins Return on Equity Return on Assets Mobilicom N/A N/A N/A Mainz Biomed N/A N/A N/A

Do analysts rate QUCY or TPCS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25 Techprecision 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate QUCY or SYPR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25 Sypris Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer QUCY or XTIA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25 XTI Aerospace 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Mainz Biomed (QUCY) Competitors

$1.33 +0.01 (+0.76%)

Closing price 09/24/2026 04:00 PM Eastern

Extended Trading

$1.34 +0.01 (+0.60%)

As of 06:17 AM Eastern

Compare

QUCY vs. OPXS, MOB, TPCS, SYPR, and XTIA

Should you buy Mainz Biomed stock or one of its competitors? Mainz Biomed's main competitors and comparable companies include Optex Systems (OPXS), Mobilicom (MOB), Techprecision (TPCS), Sypris Solutions (SYPR), and XTI Aerospace (XTIA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "aerospace & defense" industry.

How does Mainz Biomed compare to Optex Systems?

Mainz Biomed (NASDAQ:QUCY) and Optex Systems (NASDAQ:OPXS) are both small-cap industrials companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

Mainz Biomed has a beta of 2.35, suggesting that its share price is 135% more volatile than the broader market. Comparatively, Optex Systems has a beta of 0.48, suggesting that its share price is 52% less volatile than the broader market.

19.1% of Optex Systems shares are owned by institutional investors. 3.1% of Mainz Biomed shares are owned by company insiders. Comparatively, 27.7% of Optex Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Optex Systems has a net margin of 9.77% compared to Mainz Biomed's net margin of 0.00%. Optex Systems' return on equity of 17.57% beat Mainz Biomed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
Optex Systems	9.77%	17.57%	14.65%

Optex Systems has higher revenue and earnings than Mainz Biomed. Mainz Biomed is trading at a lower price-to-earnings ratio than Optex Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$540K	36.11	-$16.21M	-$10.37	N/A
Optex Systems	$41.34M	1.76	$5.15M	$0.55	19.00

In the previous week, Optex Systems had 1 more articles in the media than Mainz Biomed. MarketBeat recorded 2 mentions for Optex Systems and 1 mentions for Mainz Biomed. Mainz Biomed's average media sentiment score of 1.79 beat Optex Systems' score of 0.87 indicating that Mainz Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Mainz Biomed	Very Positive
Optex Systems	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
Optex Systems	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	3.00

Summary

Optex Systems beats Mainz Biomed on 11 of the 14 factors compared between the two stocks.

How does Mainz Biomed compare to Mobilicom?

Mobilicom (NASDAQ:MOB) and Mainz Biomed (NASDAQ:QUCY) are both small-cap industrials companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobilicom	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25

Company	Net Margins	Return on Equity	Return on Assets
Mobilicom	N/A	N/A	N/A
Mainz Biomed	N/A	N/A	N/A

Mobilicom has a beta of 2.26, meaning that its stock price is 126% more volatile than the broader market. Comparatively, Mainz Biomed has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market.

In the previous week, Mobilicom and Mobilicom both had 1 articles in the media. Mobilicom's average media sentiment score of 1.79 equaled Mainz Biomed'saverage media sentiment score.

Company	Overall Sentiment
Mobilicom	Very Positive
Mainz Biomed	Very Positive

13.6% of Mobilicom shares are held by institutional investors. 7.2% of Mobilicom shares are held by insiders. Comparatively, 3.1% of Mainz Biomed shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Mainz Biomed has lower revenue, but higher earnings than Mobilicom.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobilicom	$3.36M	18.10	-$23.73M	N/A	N/A
Mainz Biomed	$540K	36.11	-$16.21M	-$10.37	N/A

Summary

Mainz Biomed beats Mobilicom on 5 of the 9 factors compared between the two stocks.

How does Mainz Biomed compare to Techprecision?

Mainz Biomed (NASDAQ:QUCY) and Techprecision (NASDAQ:TPCS) are both small-cap industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Mainz Biomed has a beta of 2.35, meaning that its share price is 135% more volatile than the broader market. Comparatively, Techprecision has a beta of 0.41, meaning that its share price is 59% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
Techprecision	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Techprecision has higher revenue and earnings than Mainz Biomed. Techprecision is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$540K	36.11	-$16.21M	-$10.37	N/A
Techprecision	$33.36M	1.60	-$1.66M	-$0.13	N/A

15.5% of Techprecision shares are held by institutional investors. 3.1% of Mainz Biomed shares are held by insiders. Comparatively, 15.1% of Techprecision shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Mainz Biomed has a net margin of 0.00% compared to Techprecision's net margin of -3.66%. Mainz Biomed's return on equity of 0.00% beat Techprecision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
Techprecision	-3.66%	-15.07%	-3.75%

In the previous week, Techprecision had 2 more articles in the media than Mainz Biomed. MarketBeat recorded 3 mentions for Techprecision and 1 mentions for Mainz Biomed. Mainz Biomed's average media sentiment score of 1.79 beat Techprecision's score of 1.25 indicating that Mainz Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Mainz Biomed	Very Positive
Techprecision	Positive

Summary

Mainz Biomed beats Techprecision on 9 of the 15 factors compared between the two stocks.

How does Mainz Biomed compare to Sypris Solutions?

Mainz Biomed (NASDAQ:QUCY) and Sypris Solutions (NASDAQ:SYPR) are both small-cap industrials companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

44.7% of Sypris Solutions shares are owned by institutional investors. 3.1% of Mainz Biomed shares are owned by insiders. Comparatively, 47.9% of Sypris Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
Sypris Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Sypris Solutions has higher revenue and earnings than Mainz Biomed. Sypris Solutions is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$540K	36.11	-$16.21M	-$10.37	N/A
Sypris Solutions	$119.89M	0.34	-$6.34M	-$0.47	N/A

Mainz Biomed has a net margin of 0.00% compared to Sypris Solutions' net margin of -9.23%. Mainz Biomed's return on equity of 0.00% beat Sypris Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
Sypris Solutions	-9.23%	-67.14%	-9.87%

In the previous week, Mainz Biomed and Mainz Biomed both had 1 articles in the media. Sypris Solutions' average media sentiment score of 1.84 beat Mainz Biomed's score of 1.79 indicating that Sypris Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
Mainz Biomed	Very Positive
Sypris Solutions	Very Positive

Mainz Biomed has a beta of 2.35, meaning that its share price is 135% more volatile than the broader market. Comparatively, Sypris Solutions has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

Mainz Biomed beats Sypris Solutions on 8 of the 14 factors compared between the two stocks.

How does Mainz Biomed compare to XTI Aerospace?

Mainz Biomed (NASDAQ:QUCY) and XTI Aerospace (NASDAQ:XTIA) are both small-cap industrials companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Mainz Biomed has a net margin of 0.00% compared to XTI Aerospace's net margin of -171.13%. Mainz Biomed's return on equity of 0.00% beat XTI Aerospace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
XTI Aerospace	-171.13%	-2,044.78%	-105.02%

In the previous week, XTI Aerospace had 16 more articles in the media than Mainz Biomed. MarketBeat recorded 17 mentions for XTI Aerospace and 1 mentions for Mainz Biomed. Mainz Biomed's average media sentiment score of 1.79 beat XTI Aerospace's score of 0.07 indicating that Mainz Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Mainz Biomed	Very Positive
XTI Aerospace	Neutral

Mainz Biomed has higher earnings, but lower revenue than XTI Aerospace. XTI Aerospace is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$540K	36.11	-$16.21M	-$10.37	N/A
XTI Aerospace	$22.49M	1.64	-$68.76M	-$5.20	N/A

11.7% of XTI Aerospace shares are held by institutional investors. 3.1% of Mainz Biomed shares are held by insiders. Comparatively, 7.4% of XTI Aerospace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
XTI Aerospace	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Mainz Biomed has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market. Comparatively, XTI Aerospace has a beta of 4.79, suggesting that its stock price is 379% more volatile than the broader market.

Summary

Mainz Biomed and XTI Aerospace tied by winning 7 of the 14 factors compared between the two stocks.

Get Mainz Biomed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QUCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QUCY vs. The Competition

Export

Metric	Mainz Biomed	Aerospace & Defense Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$19.35M	$20.63B	$10.34B	$13.29B
Dividend Yield	N/A	1.68%	96.94%	12.57%
P/E Ratio	-0.13	37.57	25.23	25.76
Price / Sales	36.11	143.27	288.99	106.83
Price / Cash	N/A	26.28	24.10	52.76
Price / Book	19.00	7.40	4.82	6.34
Net Income	-$16.21M	$567.30M	$613.71M	$360.00M
7 Day Performance	-3.62%	0.16%	0.46%	-0.18%
1 Month Performance	-2.21%	-6.84%	-2.93%	-4.09%
1 Year Performance	N/A	1.99%	4.48%	5.97%

Mainz Biomed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QUCY Mainz Biomed	1.7516 of 5 stars	$1.33 +0.8%	N/A	N/A	$19.35M	$540K	N/A	13	Positive News
OPXS Optex Systems	2.6186 of 5 stars	$10.50 -0.1%	N/A	-20.6%	$73.08M	$39.80M	19.09	95	Positive News Gap Down
MOB Mobilicom	1.3638 of 5 stars	$5.04 +1.8%	N/A	-99.8%	$61.56M	$3.64M	N/A	38	Positive News
TPCS Techprecision	1.0961 of 5 stars	$5.40 -0.2%	N/A	+1.2%	$54.70M	$31.64M	N/A	160	News Coverage Positive News
SYPR Sypris Solutions	0.7344 of 5 stars	$1.73 -1.7%	N/A	-21.0%	$39.84M	$119.89M	N/A	548	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QUCY) was last updated on 9/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mainz Biomed (QUCY) Competitors

QUCY vs. OPXS, MOB, TPCS, SYPR, and XTIA

How does Mainz Biomed compare to Optex Systems?

Summary

How does Mainz Biomed compare to Mobilicom?

Summary

How does Mainz Biomed compare to Techprecision?

Summary

How does Mainz Biomed compare to Sypris Solutions?

Summary

How does Mainz Biomed compare to XTI Aerospace?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QUCY vs. The Competition

Mainz Biomed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mainz Biomed (QUCY) Competitors

QUCY vs. OPXS, MOB, TPCS, SYPR, and XTIA

How does Mainz Biomed compare to Optex Systems?

Which has more volatility and risk, QUCY or OPXS?

Do insiders and institutionals believe in QUCY or OPXS?

Is QUCY or OPXS more profitable?

Which has better valuation & earnings, QUCY or OPXS?

Does the media prefer QUCY or OPXS?

Do analysts prefer QUCY or OPXS?

Summary

How does Mainz Biomed compare to Mobilicom?

Do analysts rate MOB or QUCY?

Is MOB or QUCY more profitable?

Which has more volatility & risk, MOB or QUCY?

Does the media favor MOB or QUCY?

Do insiders and institutionals hold more shares of MOB or QUCY?

Which has higher earnings & valuation, MOB or QUCY?

Summary

How does Mainz Biomed compare to Techprecision?

Which has more risk & volatility, QUCY or TPCS?

Do analysts rate QUCY or TPCS?

Which has better valuation and earnings, QUCY or TPCS?

Do institutionals and insiders hold more shares of QUCY or TPCS?

Is QUCY or TPCS more profitable?

Does the media refer more to QUCY or TPCS?

Summary

How does Mainz Biomed compare to Sypris Solutions?

Do insiders and institutionals hold more shares of QUCY or SYPR?

Do analysts rate QUCY or SYPR?

Which has higher earnings & valuation, QUCY or SYPR?

Is QUCY or SYPR more profitable?

Does the media refer more to QUCY or SYPR?

Which has more volatility & risk, QUCY or SYPR?

Summary

How does Mainz Biomed compare to XTI Aerospace?

Is QUCY or XTIA more profitable?

Does the media refer more to QUCY or XTIA?

Which has better earnings and valuation, QUCY or XTIA?

Do institutionals and insiders hold more shares of QUCY or XTIA?

Do analysts prefer QUCY or XTIA?

Which has more volatility & risk, QUCY or XTIA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QUCY vs. The Competition

Mainz Biomed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools